The Q4 earnings report for Enanta Pharma ENTA was released on Monday, November 25, 2024 at 04:01 PM.
Here's what investors need to know about the latest announcement.
Earnings
Enanta Pharma beat estimated earnings by 4.0%, reporting an EPS of $-1.36 versus an estimate of $-1.41.
Revenue was down $4.33 million from the same period last year.
Previous Earnings Records
During the previous quarter, the company beat on EPS by $0.38, leading to a 1.0% increase share price change the next day.
Here's a look at Enanta Pharma's past performance:
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Estimate | -1.45 | -1.33 | -1.19 | -2 |
| EPS Actual | -1.07 | -1.47 | -1.58 | -1.33 |
| Revenue Estimate | 17.18M | 16.52M | 21.28M | 17.50M |
| Revenue Actual | 17.97M | 17.05M | 18.00M | 18.93M |
To track all earnings releases for Enanta Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
